SML4024
PZ-1922
≥95% (HPLC)
别名:
1-(3-Chlorobenzyl)-4-(piperazin-1-yl)-1H-pyrrolo[3,2-c]quinoline hydrochloride, 1-[(3-Chlorophenyl)methyl]-4-(1-piperazinyl)-1H-pyrrolo[3,2-c]quinoline hydrochloride, PZ 1922 hydrochloride, PZ1922 hydrochloride
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
经验公式（希尔记法）:
C22H21ClN4 · xHCl
化学文摘社编号:
分子量:
376.88 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.21
Assay:
≥95% (HPLC)
Form:
powder
Storage condition:
desiccated
Quality Segment
assay
≥95% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
ClC1=CC(CN2C=CC3=C2C4=CC=CC=C4N=C3N5CCNCC5)=CC=C1
InChI key
MFUVKDHSDIAPMH-UHFFFAOYSA-N
Biochem/physiol Actions
Bioavailable triple acting, selective, high affinity 5-HT6R/5-HT3R dual antagonist and MAO-B reversible inhibitor; anti-AD agent.
PZ-1922 is a piperazinyl-pyrroloquinoline analog with favorable oral absorption and CNS penetration that simultaneously targets 5-HT6R (Ki = 17 nM), 5-HT3R (Ki = 0.45 nM), and MAO-B (pIC50 = 8.93). PZ1922 shows high selectivity over a selected panel of GPCRs, MAO-A and hERG. PZ 1922 effectively reverses cognitive impairment, prevents Aβ-induced memory decline in rodent models of Alzheimer’s disease (AD) (1.5 mg/kg/ip injection) and modulates neuroinflammatory processes.
PZ-1922 is a piperazinyl-pyrroloquinoline analog with favorable oral absorption and CNS penetration that simultaneously targets 5-HT6R (Ki = 17 nM), 5-HT3R (Ki = 0.45 nM), and MAO-B (pIC50 = 8.93). PZ1922 shows high selectivity over a selected panel of GPCRs, MAO-A and hERG. PZ 1922 effectively reverses cognitive impairment, prevents Aβ-induced memory decline in rodent models of Alzheimer’s disease (AD) (1.5 mg/kg/ip injection) and modulates neuroinflammatory processes.
Disclaimer
Hygroscopic
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable